Integra Lifesciences Holdings Corp reports results for the quarter ended in March - Earnings Summary

Integra LifeSciences Holdings

26/04/2023 14:31

* Integra Lifesciences Holdings Corp  IART.OQ  reported
quarterly
adjusted earnings of 74 cents​​ per share for the quarter ended
in March. The mean expectation of thirteen analysts for the
quarter was for earnings of 74 cents per share.
    * Revenue rose 1.1% to $380.85 million from a year ago;
analysts
expected $373.21 million. 
    * Integra Lifesciences Holdings Corp's reported EPS for the
quarter was 29 cents​.
    * The mean earnings estimate of analysts had fallen by
about 7.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Integra Lifesciences Holdings Corp shares had risen
by 2.5% this
quarter and gained 4.9% so far this year.
    * The company reported quarterly net income of $24.23
million.
    * Wall Street's median 12-month price target for Integra
Lifesciences Holdings Corp is $59.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 9
"hold" and 2 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
April 26 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      0.74           0.74           Met
 Dec. 31 2022      0.90           0.94           Beat
 Sep. 30 2022      0.72           0.86           Beat
 Jun. 30 2022      0.80           0.81           Beat